Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.


  1. Búsqueda avanzada de patentes
Número de publicaciónUS2671451 A
Tipo de publicaciónConcesión
Fecha de publicación9 Mar 1954
Fecha de presentación16 Jun 1952
Fecha de prioridad16 Jun 1952
Número de publicaciónUS 2671451 A, US 2671451A, US-A-2671451, US2671451 A, US2671451A
InventoresBolger Stephen J
Cesionario originalBolger Stephen J
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Remedial pill
US 2671451 A
Resumen  disponible en
Previous page
Next page
Reclamaciones  disponible en
Descripción  (El texto procesado por OCR puede contener errores)

5. J. BOLGER REMEDIAL PILL March 9, 1954 Filed June 16, 1952 INVENTOR fiephen' JLBO {9 mauw ATTORNEY Patented Mar. 9, 1954 UNITED STATES PATENT OFFICE 3 Claims.

The present invention relates to remedies and more particularly to pill-type remedies and a method of treating internal disorders.

In localized disorders of the alimentary canal, particularly ulcers, it is very diflicult to apply a remedy to the affected spot for the reason that there is a constant flow through the canal caused by the normal digestive processes. Any remedy in the form of a tablet or pill is therefore quickly washed past the affected spot and consequently has very little or no remedial efiect. There are known remedies which, if they could be made to stop at or near the affected spot, would slowly dissolve, with a highly beneficial effect.

The objects of this invention are, therefore, to provide an efiicacious method of treating such localized internal disorders, and more specifically to provide a special type of pill to be used in connection with the method.

Illustrative embodiments of the invention are shown in the accompanying drawing, wherein:

Figure 1 is a front view of a human torso showing parts of the alimentary canal in cutaway view;

Figure 2 is a similar view of a human torso showing parts of the alimentary canal in dotted lines and illustrating the first step in practicing my new method;

Figure 3 is a cutaway view of a part of the alimentary canal showing the esophagus, the stomach, the pylorus and the duodenum, which view illustrates another step in the practice of my new method;

Figure 4 is a central sectional view through a spherical pill made according to the invention; and

Figure 5 is a. perspective view of a lozenge or tablet form of the pill.

Referring now in detail to these drawings, Figures 1 and 2 show the human torso generally designated l and parts of the alimentary canal comprising the esophagus II, the stomach l2, and the intestines which are generally designated I3.

Any part of the alimentary canal might be locally affected as by an ulcer, and if so afiected could be treated according to my new method. However for the purpose oi illustration I have shown in Figure 3 the pylorus ll affected by an ulcer I 5.

In treating the ulcer according to my method, I first apply to the exterior of the human torso nearest the ulcer a powerful magnet l6 (see Figure 2) here shown as a bar magnet secured Cir in position as by means of adhesive tape II. It will be understood that any other form of magnet such as an electromagnet might be used in place of the magnet IB. Next I administer to the patient, who is preferably in a reclining position, a special pill generally designated 18 in Figure 3. This special pill forms a part of my invention, and comprises a body of the prescribed remedial substance having a, magnetically attractable metallic element associated therewith. The pill illustrated in Figure 4 is of spherical form, having a body 19 of the remedial substance and a spherical core 28 of iron or other magnetically attractable metal. The pill shown in Figure 5 is similar, comprising a lozenge-type body 2| of the remedial substance and a core 22 of magnetically attractable metal.

When the pill has passed through the alimentary canal to a point at or near the ulcer IE, it is halted in its passage by the magnet "S, whereupon the pill slowly dissolves in the immediate vicinity of the ulcer with beneficial efiects thereon. When the pill has completely dissolved the magnet IB is removed from the patient's body and the metallic core of the pill passes harmlessly therethrough.

While I have described but one application of my invention, and indicated others, it will be understood that the method and the form of pill might find numerous other applications falllng within the scope of the following claims.

I claim:

1. A remedial pill comprising a remedial substance which is soluble in the human body and a. magnetically attractable metallic element associated with said substance.

2. A remedial pill having a core of magnetically attractable metal encased in a remedial substance which is soluble in the human body.

3. A spherical remedial pill having a spherical core of magnetically attractable metal.


References Cited in the file of this patent UNITED STATES PATENTS Number Name Date 1,505,209 Leach et al Aug. 19, 1924 2,483,098 Millard Sept. 27, 1949 2,518,758 Cook Aug. 15, 1950 FOREIGN PATENTS Number Country Date 485,378 Great Britain May 18, 1938

Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US1505209 *12 May 192219 Ago 1924Leach Albert ARadium-carrying device
US2483098 *9 Ene 194627 Sep 1949Millard Everett LSupplying agents to the digestive tract
US2518758 *22 Jun 194915 Ago 1950George B CookMagnetic stirring apparatus
GB485378A * Título no disponible
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US2863458 *4 Sep 19579 Dic 1958Bambara John PVein stripper and a method of stripping veins
US2921584 *17 Dic 195419 Ene 1960Honeywell Regulator CoVessel occluder
US2971916 *30 Ene 195714 Feb 1961Ncr CoMicroscopic capsules containing magnetizable material
US3042616 *26 Ago 19583 Jul 1962IbmProcess of preparing magnetic ink
US3056724 *24 Sep 19582 Oct 1962Commw Scient Ind Res OrgTherapeutic pellets for ruminants
US3057344 *21 May 19579 Oct 1962Alberto Abella CarlosCapsule for the study of the digestive tract and method of using the same
US3118439 *19 Mar 195821 Ene 1964Jean-Pierre PerrenoudDiagnostic and medicating capsule and the method of use
US3146169 *8 Jun 196225 Ago 1964Burroughs Wellcome CoPharmaceutical formulations and their manufacture
US3421210 *2 Ago 196514 Ene 1969Nitroglycerin AbMethod for the manufacture of the fuse head element of electric fuses
US3474777 *10 Feb 196628 Oct 1969Amp IncMethod of administering therapeutic agents
US3592185 *18 Abr 196713 Jul 1971Yeda Res & DevFerromagnetic contrast media and method of use
US3608549 *15 Ene 197028 Sep 1971Merrill Edward WilsonMethod of administering drugs and capsule therefor
US4030499 *7 Jun 197621 Jun 1977Louis BucaloMethod and apparatus for providing living beings with absorbable implants
US4162679 *28 Sep 197731 Jul 1979Reenstierna Erik G BMethod and device for the implantation of one or more pacemaker electrodes in a heart
US4247406 *23 Abr 197927 Ene 1981Widder Kenneth JIntravascularly-administrable, magnetically-localizable biodegradable carrier
US4331654 *13 Jun 198025 May 1982Eli Lilly And CompanyDrug carrier formulation
US4830855 *13 Nov 198716 May 1989Landec Labs, Inc.Temperature-controlled active agent dispenser
US4878905 *10 Ago 19887 Nov 1989Blass Karl GGastrointestinal module: a nonsurgical implant
US5079006 *13 Jul 19887 Ene 1992Aprex CorporationPharmaceutical compositions containing a magnetically detectable material
US5162037 *7 May 199110 Nov 1992Whitson Laboratories, Inc.Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
US5401516 *22 Abr 199328 Mar 1995Emisphere Technologies, Inc.Encapsulation of biologically active materials, drug delivery, reaction with benzenesulfonyl chloride or benzoyl chloride
US5443841 *27 Jul 199222 Ago 1995Emisphere Technologies, Inc.Proteinoid microspheres and methods for preparation and use thereof
US5447728 *16 Dic 19935 Sep 1995Emisphere Technologies, Inc.A carrier comprising an acylated amino acid; lowering iron concentration in mammals
US5529568 *18 Mar 199425 Jun 1996Surgery Futures Research, Inc.Magnetic operating table
US5540939 *25 Abr 199430 Jul 1996Emisphere Technologies, Inc.Encapsulating active materials
US5541155 *22 Abr 199430 Jul 1996Emisphere Technologies, Inc.Acids and acid salts and their use in delivery systems
US5578323 *14 Jun 199326 Nov 1996Emisphere Technologies, Inc.Proteinoid carriers and methods for preparation and use thereof
US5593379 *5 Jun 199514 Ene 1997Surgery Futures Research, Inc.For carrying out laparoscopic surgery of an intestine
US5601846 *9 May 199511 Feb 1997Emisphere Technologies, Inc.Oligopeptide
US5629020 *22 Abr 199413 May 1997Emisphere Technologies, Inc.Delivery of sensitive agents such as bioactive peptides
US5643957 *25 Oct 19941 Jul 1997Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5650386 *31 Mar 199522 Jul 1997Emisphere Technologies, Inc.Compositions for oral delivery of active agents
US5667806 *7 Jun 199516 Sep 1997Emisphere Technologies, Inc.Spray drying method and apparatus
US5693338 *29 Sep 19942 Dic 1997Emisphere Technologies, Inc.Delivery composition comprising active agent, diketopiperazine, enzyme inhibitor
US5709861 *13 Ene 199520 Ene 1998Emisphere Technologies, Inc.Compositions for the delivery of antigens
US5714167 *25 Oct 19943 Feb 1998Emisphere Technologies, Inc.Reversibly forming supramolecular complex of active agent with perturbant; drug delivery
US5750147 *7 Jun 199512 May 1998Emisphere Technologies, Inc.Fungicides for oral administration
US5766633 *22 Abr 199416 Jun 1998Emisphere Technologies, Inc.Modified amino acid carrier, bioactive peptides
US5792451 *2 Mar 199411 Ago 1998Emisphere Technologies, Inc.Oral drug delivery compositions and methods
US5804688 *7 Feb 19978 Sep 1998Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5811127 *24 Oct 199422 Sep 1998Emisphere Technologies, Inc.Desferrioxamine oral delivery system
US5820881 *28 Abr 199513 Oct 1998Emisphere Technologies, Inc.Microspheres of diamide-dicarboxylic acids
US5824345 *7 Jun 199520 Oct 1998Emisphere Technologies, Inc.Microsphere comprising active agent, proteinoid, modified hydrolyzed vegetable protein
US5840340 *30 Ago 199624 Nov 1998Emisphere Technologies, Inc.Oligopeptides with fragrance, cosmetics and dye
US5863944 *30 Abr 199726 Ene 1999Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5866536 *6 Feb 19972 Feb 1999Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5876710 *7 Feb 19972 Mar 1999Emisphere Technologies Inc.Drug delivery; using a brominated benzamide compound
US5879681 *7 Feb 19979 Mar 1999Emisphere Technolgies Inc.Compounds and compositions for delivering active agents
US5939381 *7 Feb 199717 Ago 1999Emisphere Technologies, Inc.4-(4-(phenoxyacetyl)aminophenyl)butyric acid as a carrier for drug delivery
US5955503 *6 Feb 199721 Sep 1999Emisphere Technologies, Inc.Modified amino acid compounds useful as carriers in the delivery of biologically active agents such as, for example, bioactive peptides and the like
US5958457 *10 May 199528 Sep 1999Emisphere Technologies, Inc.Compositions for the delivery of antigens
US5962710 *9 May 19975 Oct 1999Emisphere Technologies, Inc.Reacting an oligosalicylate and an amino acid
US5965121 *6 Feb 199712 Oct 1999Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5972387 *21 Nov 199426 Oct 1999Emisphere Technologies, Inc.Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
US5976569 *29 Abr 19972 Nov 1999Emisphere Technologies, Inc.Diketopiperazine-based delivery systems
US5989539 *6 Feb 199723 Nov 1999Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5990166 *7 Feb 199723 Nov 1999Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6001347 *6 Feb 199714 Dic 1999Emisphere Technologies, Inc.Organic acid compound of given structure having an aromatic amide group, a methoxy group in the ortho position on the aromatic ring, and a lipophilic chain terminated with a carboxylic acid is useful as a nontoxic carrier
US6051258 *7 Jun 199518 Abr 2000Emisphere Technologies, Inc.Proteinoid emulsions and methods for preparation and use thereof
US6060513 *7 Feb 19979 May 2000Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6071510 *23 Abr 19976 Jun 2000Emisphere Technologies, Inc.Modified amino acids and compositions comprising the same for delivering active agents
US6071538 *30 Sep 19976 Jun 2000Emisphere Technologies, Inc.Oral delivery composition comprising supramolecular complex
US6084112 *10 Sep 19964 Jul 2000Emisphere Technologies, Inc.Method for preparing ω-aminoalkanoic acid derivatives from cycloalkanones
US6090958 *7 Feb 199718 Jul 2000Emisphere Technologies, Inc.N-(8-carboxyoctyl)-o-hydroxybenzamide and salts
US6099856 *10 Dic 19968 Ago 2000Emisphere Technologies, Inc.Increased bioavailable
US6100285 *11 Nov 19978 Ago 2000Emisphere Technologies, Inc.Method of solubilizing itraconazole
US6100298 *6 Feb 19978 Ago 2000Emisphere Technologies, Inc.Mixture of drug and n-(4-(carboxypropyl)phenyl-4-phenyl-butyramide for improved oral drug delivery
US61801402 Jun 199530 Ene 2001Emisphere Technologies, Inc.Modified amino acids for drug delivery
US622136729 Sep 199724 Abr 2001Emisphere Technologies, Inc.Exposing a biologically active agent to a complexing perturbant to reversibly transform the biologically active agent to the intermediate state and to form a transportable supramolecular complex
US624249516 Jun 20005 Jun 2001Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US624535930 Sep 199712 Jun 2001Emisphere Technologies, Inc.Active agent transport systems
US63130887 Feb 19976 Nov 2001Emisphere Technologies, Inc.Carriers used to deliver various active agents through various biological, chemical, and physical barriers
US633131830 Sep 199418 Dic 2001Emisphere Technologies Inc.Carbon-substituted diketopiperazine delivery systems
US63462428 Feb 200012 Feb 2002Emishpere Technologies, Inc.Compounds and compositions for delivering active agents
US634820730 Sep 199719 Feb 2002Emisiphere Technologies, Inc.Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and form orally deliverable supramolecular complex, orally administering complex to subject
US637598312 Jun 199723 Abr 2002Emisphere Technologies, Inc.Microencapsulated fragrances and method for preparation
US641355023 Nov 19982 Jul 2002Emisphere Technologies, Inc.Proteinoid carriers and methods for preparation and use thereof
US64287805 May 19996 Ago 2002Emisphere Technologies, Inc.Modified amino acid
US64615456 Ene 20008 Oct 2002Emisphere Technologies, Inc.Method of solubilizing and encapsulating itraconazole
US741702211 Abr 200526 Ago 2008Mhr Institutional Partners Iia LpAmino acid for deliverying active materials; bioavailability
US755387213 Feb 200630 Jun 2009Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US868615410 Jun 20091 Abr 2014Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
USRE35862 *14 Ago 198728 Jul 1998Emisphere Technologies, Inc.Delivery systems for pharmacological agents encapsulated with proteinoids
EP0000667A1 *28 Jul 19787 Feb 1979Northwestern UniversityIntravascularly-administrable, magnetically-localizable biodegradable carrier and process for its preparation
EP0042249A210 Jun 198123 Dic 1981Northwestern UniversityMagnetically-localizable, biodegradable lipid microspheres
EP0409893A1 *3 Abr 198930 Ene 1991FISCHMAN, Walter WhitsonMagnetically influenced homeopathic pharmaceutical formulations and methods of their preparation
EP0773005A113 Nov 199514 May 1997Surgery Futures Research Inc.Magnetic operation table
Clasificación de EE.UU.604/288, 600/12, 252/62.55, 335/285, 604/57
Clasificación internacionalA61K9/50
Clasificación cooperativaA61K9/5094
Clasificación europeaA61K9/50T